Home » Topics » Regulatory

Regulatory
RSS

FDA clears Optison

Jan. 8, 1998

NDA filed for betamethasone mousse

Jan. 7, 1998

Astra to launch new tablet formulation of Losec in Sweden

Jan. 7, 1998

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

Faulding establishes new U.S. division, regains rights to Kadian

Jan. 7, 1998

NDA filed for extended-release Ditropan formulation

Dec. 29, 1997

Alferon evaluated in patients coinfected with HIV and HCV

Dec. 29, 1997

FDA approval obtained for Prandin

Dec. 29, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

FDA clears new oral treatment for hair loss in men

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...